CA9 and nonpapillary renal cell carcinoma: Chang et al. (2015) tested the antitumor activity of some of these human anti-CAIX antibodies on ccRCC lines in vitro, including SK-RC-09 (high CAIX expression), SK-RC-52 (moderate CAIX expression), and SK-RC-59 (originally negative for CAIX).